DarioHealth (DRIO) Tops Q4 EPS by 92c, Miss on Revenues

DarioHealth (NASDAQ: DRIO) reported Q4 EPS of $0.45, $0.92 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $1.01 million versus the consensus estimate of $1.16 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Mattel (MAT) Tops Q1 EPS by 7c, Revenue Misses, Offers Guidance
• EQT Corp. (EQT) Tops Q1 EPS by 17c; offers outlook